Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Ingresos
100
38
7
53
47
38
Crecimiento de los Ingresos (YoY)
186%
443%
-87%
13%
24%
-17%
Costo de los ingresos
49
21
6
36
32
25
Utilidad bruta
50
17
1
16
15
12
Venta, General y Administración
60
45
11
24
27
10
Investigación y Desarrollo
16
5
3
7
0
--
Gastos de Operación
90
50
18
36
31
13
Otras Ingresos (Gastos) No Operativos
0
2
-1
1
0
1
Ingreso antes de impuestos
-49
-28
-32
-19
-16
-1
Gasto por Impuesto a la Renta
-1
0
0
1
0
0
Ingreso Neto
-59
-26
-31
-21
-15
-1
Crecimiento de la Utilidad Neta
18%
-16%
48%
40%
1,400%
--
Acciones en Circulación (Diluidas)
237.81
135.56
57.03
50.08
48
38.33
Cambio de Acciones (YoY)
46%
138%
14%
4%
25%
-53%
EPS (Diluido)
-0.24
-0.19
-0.56
-0.42
-0.33
-0.03
Crecimiento de EPS
-20%
-66%
34%
27%
1,000%
--
Flujo de efectivo libre
-25
-23
-10
-9
-9
3
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
50%
44.73%
14.28%
30.18%
31.91%
31.57%
Margen de operación
-39%
-86.84%
-228.57%
-35.84%
-34.04%
0%
Margen de beneficio
-59%
-68.42%
-442.85%
-39.62%
-31.91%
-2.63%
Margen de flujo de caja libre
-25%
-60.52%
-142.85%
-16.98%
-19.14%
7.89%
EBITDA
-23
-26
-13
-14
-12
2
Margen de EBITDA
-23%
-68.42%
-185.71%
-26.41%
-25.53%
5.26%
D&A para EBITDA
16
7
3
5
4
2
EBIT
-39
-33
-16
-19
-16
0
Margen de EBIT
-39%
-86.84%
-228.57%
-35.84%
-34.04%
0%
Tasa de Impuesto Efectiva
2.04%
0%
0%
-5.26%
0%
0%
Estadísticas clave
Cierre Anterior
$0.5095
Precio de apertura
$0.494
Rango del día
$0.48 - $0.5107
Rango de 52 semanas
$0.48 - $1.41
Volumen
12.7K
Volumen promedio
140.4K
EPS (TTM)
-0.17
Rendimiento de dividendos
--
Cap. de mercado
$133.6M
¿Qué es HealWELL AI Inc.?
HealWELL AI, Inc. is a health care technology company, which focuses on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. The company is headquartered in Toronto, Ontario and currently employs 350 full-time employees. The company went IPO on 2007-04-25. The Company, using its own proprietary technology, is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases. The firm's segments include Clinical Research and Patient services, AI and Data sciences and Healthcare Software. The Clinical Research and Patient Services segment includes clinical research contracts and medical consultations provided through the Company's MCI Polyclinic Group Inc. and BioPharma subsidiaries in Ontario. The AI and Data Sciences segment includes integration of advanced AI and data science technologies in healthcare through its Khure Health Inc. and Pentavere and Mutuo subsidiaries. The Healthcare Software segment includes Intrahealth and Versource healthcare software-as-a-service.